2m 2m 2m 2m 2m 2m 2m
Invivyd (IVVD)
NASDAQ
$0.60+$0.03 (+4.81%)
Price as of Nov 11, 2026 7:39 PM EST- $169.3MMarket Cap
- -65.19%1-Year Change
- BiotechnologyIndustry
Invivyd (IVVD)
$0.60+$0.03 (+4.81%)
IVVD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.57 | ||
Change | -$0.02 (-3.66%) | ||
Open | $0.57 | ||
High | $0.61 | ||
Low | $0.56 | ||
Previous Close | $0.60 | ||
Volume | 2,869,261 | ||
30-Day Average Volume | 3,934,858 | ||
1-Week Change | -1.22% | ||
1-Month Change | -20.35% | ||
1-Year Change | -65.19% | ||
3-Year Change | -58.97% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 294.8M | ||
Total Assets | $218.9M | ||
Market Cap | $169.3M | ||
Enterprise Value | $9.2M | ||
Period: QTR TTM FY | |||
Revenue | $14.3M | ||
Net Income | -$44.4M | ||
Free Cash Flow | -$43.5M | ||
EBIT | -$44.4M | ||
EBITDA | -$44.2M | ||
Net Working Capital | $151.1M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 1 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue